Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma

Acta Ophthalmologica Scandinavica

Volumn 75, Issue 2, 1997, Pages 148-154

  Seregard, Stefan ^a   Lundell, Göran ^b   Lax, Ingmar ^c   Trampe, Eva Af ^a   Kock, Erik ^a  

^a ST ERIK S EYE HOSPITAL   (Sweden)

^b Radiumhemmet   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Failed plaque radiotherapy; PC 10 antibody; Posterior uveal melanoma; Tumour cell proliferation

Indexed keywords

RUTHENIUM;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CELL COUNT; CELL PROLIFERATION; CHOROID; CILIARY BODY; ENUCLEATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROWAVE RADIATION; MITOSIS; PRIORITY JOURNAL; TREATMENT FAILURE; TUMOR CELL; UVEA MELANOMA;

EID: 0030928368     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1997.tb00112.x     Document Type: Article

References (43)

1. Adams KS, Abramson DH, Ellsworth RM, Haik BG, Deford M, Packer S, Seddon J, Albert D & Polivogianis L (1988): Cobalt plaque versus enucleation for uveal melanoma: comparison of survival rates. Br J Ophthalmol 72: 494-497.
2. Allegranza A, Girlando S, Arrigoni GL, Veronese S, Mauri FA, Gambacorta M, Pollo B, Dalla Palma P & Barbareschi M (1991): Proliferating cell nuclear antigen expression in central nervous system neoplasms. Virchows Arch A Pathol Anat Histopathol 419: 417-423.
3. Augsburger JJ, Gamel JE, Sardi VF, Greenberg RA, Shields JA & Brady LW (1986): Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol 104: 665-661.
4. Bujara K & Hallermann D (1984): Netzhaut-Aderhautnarbe nach Bestrahlung eines malignen Melanomas der Aderhaut mit dem Ruthenium-106-Applikator. Ophthalmologica 188: 29-34.
5. Burns B, Curry RH & Bell MEA (1979): Morphological features of prognostic significance in uterine smooth muscle tumors: a review of eightyfour cases. Am J Obstet Gynecol 135: 109-114.
6. Char DH, Crawford JB, Kaleta-Michaels S, Howes EL, Lovato AA & Quivey JM (1989): Analysis of radiation failure after uveal melanoma brachytherapy. Am J Ophthalmol 108: 712-716.
7. Cleasby GW & Kutzcher BM (1985): Clinico-pathological report of successful cobalt 60 plaque therapy for choroidal melanoma. Am J Ophthalmol 100: 828-830.
8. Collaborative Ocular Melanoma Study Group (1993): Design and methods of a clinical trial for a rare condition. COMS Report No. 3. Control Clin Trials 14: 362-391.
9. De Potter P, Shields CL, Shields JA, Cater JR & Tardio DJ (1994): Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival. Br J Ophthalmol 78: 109-114.
10. Fine SL (1986): Do I take the eye out or leave it in? (editorial). Arch Ophthalmol 104: 653-654.
11. Fuchs U, Kivelä T, Tarkkanen A & Laatikainen L (1988): Histopathology of enucleated intraocular melanomas with cobalt and ruthenium plaques. Acta Ophthalmol (Copenh) 66: 255-266.
12. Greenwell A, Foley JF & Maronpot RR (1991): An enhancing method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues. Cancer Lett 59: 251-256.
13. Guthoff R, Frischmuth J, Jensen OA, Bjerrum K & Pause JU (1992): Das Aderhautmelanom. Eine retrospektive randomisierte Vergleichsstudie Ruthenium-Bestrahlung vs Enukleation. Klin Monatsbl Augenheilkd 200: 257-261.
14. Guthoff R, Kleineidam M, Chumbley L, Schiller L & Beck-Bornholdt H P (1991): Der Einfluss der Dosisleistung von Ruthenium-106-Applikatoren auf die Tumorrückbildung in Tiermodell. Fortschr Ophthalmol 88: 648-650.
15. Haerslev T & Jacobsen G K (1994): Microwave processing for immunohistochemical demonstration of proliferating cell nuclear antigen (PCNA) in formalin-fixed and paraffin-embedded tissue. APMIS 102: 395-400.
16. Hall PA & Levison DA (1990): Assessment of cell proliferation in histological material. J Clin Pathol 43: 184-192.
17. Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Wasseem N & Lane DP (1990): Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferations with evidence of deregulated expression in some neoplasms. J Pathol 162: 285-294.
18. Kleineidam M, Guthoff R & Bentzen SM (1993): Rates of local control, metastasis, and overall survival in patients treated with ruthenium-106 plaques. Radiother Oncol 28: 148-156.
19. 106Rh ophthalmic applicators. Graefes Arch Clin Exp Ophthalmol 229: 480-486.
20. Landberg G & Roos G (1991): Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis. Cancer Res 51: 4570-4574.
21. Lax I (1991): Dosimetry of 106Ru eye applicators with a p-type silicon detector. Phys Med Biol 36: 963-972.
22. Liszauer AD, Brownstein S, Corriveau C & Deschenes J (1990): A clinicopathological study of seven globes enucleated after primary radiation therapy for malignant melanoma of the choroid or ciliary body. Can J Ophthalmol 25: 340-344.
23. Lommatzsch PK (1986): Results after beta-irradiation (106Ru/106Rh) of choroidalmelanomas: 20 years' experience. Br J Ophthalmol 70: 844-851.
24. Lommatzsch PK & Vollmar R (1966): Ein neuer Weg zur konservativen Therapie intraokularer Tumoren mit Betastrahlen (106-Ru/106-Rh) unter erhaltung der Sefähigkeit. Klin Monatsbl Augenheilkd 148: 682-689.
25. MacFaul PA & Morgan G (1977): Histopathological changes in malignant melanoma of the choroid after cobalt plaque therapy. Br J Ophthalmol 61: 221-228.
26. McLean IW, Foster WD & Zimmerman LE (1983): Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 96: 502-509.
27. Messmer E, Bornfeld N, Foerster M, Schilling H & Wessing A (1992): Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma. Graefes Arch Clin Exp Ophthalmol 230: 391-396.
28. Mooy CM, de Jong PTVM, van der Kwast TH, Mulder PGH, Jager M & Ruiter DJ (1990): Ki-67 immunostaining in uveal melanoma. The effect of pre-enucleation radiotherapy. Ophthalmology 97: 1275-1280.
29. Morris GF & Mathews MB (1989): Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 264: 13856-13864.
30. Pe'er J, Gnessin H, Shargal Y & Livni N (1994): PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirridiation groups. Ophthalmology 101: 56-62.
31. Seregard S (1993): Cell proliferation as a prognostic indicator in conjunctival malignant melanoma. Am J Ophthalmol 116: 93-97.
32. Seregard S (1996): Cell growth and p53 expression in primary acquired melanosis and conjunctival melanoma. J Clin Pathol 49: 338-342.
33. Seregard S, Oskarsson M & Spångborg B (1996): PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma. Invest Ophthalmol Vis Sci 37: 1451-1458.
34. Seregard S, af Trampe E, Lax I, Kock E & Lundell G (1997): Results following episcleral ruthenium plaque radiotherapy for posterior uveal melanoma. The Swedish experience. Acta Ophthalmol Scand 75: 11-16.
35. Shields CL, Shields JA, Karlsson U, Markoe AM & Brady LW (1989): Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma. Clinical findings. Ophthalmology 96: 919-924.
36. Shields CL, Shields JA, Karlsson U, Menduke H & Brady LW (1990): Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings. Ophthalmology 97: 1665-1670.
37. Shields JA, Shields CL & Donoso LA (1991): Management of posterior uveal melanoma. Surv Ophthalmol 36: 161-195.
38. Silverberg SG (1976): Reproducibility of the mitosis count in the histologic diagnosis of smooth muscle tumours of the uterus. Hum Pathol 7: 451-454.
39. Summanen P, Immonen I, Heikkonen J, Tommila P, Laatikainen L & Tarkkanen A (1993): Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy. Ophthalmic Surg 24: 82-90.
40. Taylor CR, Shi S-R, Chaiwun B, Young L, Imam SA & Cote RJ (1994): Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum Pathol 25: 263-70.
41. Waseem NH & Lane DP (1990): Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96: 121-129.
42. Wisjman JH, van Dierendonck J-H, Keijzer R, van de Velde CJH & Cornelisse CJ (1992): Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue. J Pathol 168: 75-83.
43. Wolf H & Dittrich KL (1992): Detection of proliferating cell nuclear antigen in diagnostic histopathology. J Histochem Cytochem 40: 1269-1273.